摘要
目的:研究分析在冠心病心衰患者治疗中采用曲美他嗪+琥珀酸美托洛尔治疗的临床应用效果与可行性。方法:收治冠心病心衰患者100例,随机分为两组,每组各50例。常规组采用常规治疗方法,研究组采用曲美他嗪+琥珀酸美托洛尔治疗,比较两组患者心功能各项指标、临床治疗总有效率等指标。结果:研究组患者与常规组患者心功能各项指标、治疗总有效率组间差异有统计学意义(P<0.05),研究组较优异。结论:在冠心病心衰患者治疗中采用曲美他嗪+琥珀酸美托洛尔治疗,有利于提高患者临床治疗总有效率,改善患者心功能各项指标。
Objective:To study the clinical application and feasibility of trimetazidine+metoprolol succinate in the treatment of patients with coronary heart disease and heart failure.Methods:100 patients with coronary heart disease and heart failure were selected,they were divided into the two groups,the conventional group used conventional treatment methods,the study group was treated with trimetazidine combined with metoprolol succinate.The indexes of cardiac function and the total effective rate of clinical treatment were compared between the two groups.Results:The difference of cardiac function and total effective rate between the study group and the routine group was statistically significant,and the study group was better(P<0.05).Conclusion:Trimetazidine+metoprolol succinate in the treatment of patients with coronary heart disease and heart failure is beneficial to improve the total effective rate of clinical treatment and improve the cardiac function indicators of patients.
作者
李芝应
Li Zhiying(The People's Hospital of Sinan County,Guizhou Province 565100)
出处
《中国社区医师》
2018年第31期8-8,10,共2页
Chinese Community Doctors
关键词
心力衰竭
曲美他嗪
琥珀酸美托洛尔
临床应用
冠心病
Heart failure
Trimetazidine
Metoprolol succinate
Clinical application
Coronary heart disease
